CUREPSP Gives Four New Grants for “Prime of Life” Neurodegenerative Diseases
source: pixabay.com

CUREPSP Gives Four New Grants for “Prime of Life” Neurodegenerative Diseases

CurePSP has just announced their latest Venture Grant recipients. These grants total $320,000 and will all support the research of neurodegenerative disease treatments. CurePSP gives these grants twice every year.…

Continue Reading CUREPSP Gives Four New Grants for “Prime of Life” Neurodegenerative Diseases
Improving Rare Disease Clinical Trials
source: pixabay.com

Improving Rare Disease Clinical Trials

Clinical trials face many obstacles regardless of which disease they aim to investigate. However, rare disease trials face additional problems that don't typically impact studies for more common conditions. Small…

Continue Reading Improving Rare Disease Clinical Trials

New Therapy for Eosinophilic Granulomatosis with Polyangiitis May be Coming to Europe

The EMA has recently published their recommendation for extending the indication of a treatment called Nucala to include patients diagnosed with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (EGPA). Specifically,…

Continue Reading New Therapy for Eosinophilic Granulomatosis with Polyangiitis May be Coming to Europe